Compare TAOP & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAOP | VVOS |
|---|---|---|
| Founded | 1993 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 15.1M |
| IPO Year | 2012 | 2020 |
| Metric | TAOP | VVOS |
|---|---|---|
| Price | $1.30 | $1.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 6.8K | ★ 83.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,031,000.00 |
| Revenue This Year | N/A | $31.42 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.91 |
| 52 Week Low | $0.14 | $1.29 |
| 52 Week High | $8.78 | $7.40 |
| Indicator | TAOP | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 34.82 |
| Support Level | $1.21 | N/A |
| Resistance Level | $1.59 | $1.88 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 19.44 | 13.61 |
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.